YOCON has been rooted in the virus sample collection, extraction and testing for over 15 years. As a key government-appointed nterprise for COVID-19 prevention and control, YOCON will develop more high-quality and innovative products, opening a new era in the field of molecular diagnosis.
With the goal of being “safer and more convenient” and decades of dedication to serum-free cell culture, YOCON is committed to producing high-quality and brand serum-free cell culture media.
A new generation of tumor cell culture medium.
Yocon provide the broadest selection of specialty products that are optimized for mesenchymal stem cell populations, which are free of animal and human derived components. These media are designed to minimize adaptation time, maximize cell performance, and meet regulatory requirements.
This product is a serum-free culture kit for pure factor culture of NK cells, suitable for NK cells culture of peripheral blood and umbilical cord blood samples.
Yocon provide the broadest selection of specialty products that are optimized for mesenchymal stem cell populations, which are free of animal and human derived components. These media are designed to minimize adaptation time, maximize cell performance, and meet regulatory requirements.
HEK 293 Suspesion Cultutre Serum-free Media
This product is an animal-derived gene-free recombinant digestive enzymes specifically designed for passage and digestion of mesenchymal stem cells, gentle and less harmful to cells, better suited for serum-free systems
No Protein, No DMSO, No Animal Origin, all ingredients are chmical defined.
This is an integrated workstation for automatic dispensing, processing and extraction of nucleic acid samples within 20 minutes
This non-inactivated virus sampling tube, which is first registered under Class II medical device in China, is suitable for collection and transport of virus samples and isolation of virus strains
This product is a non-inactivated virus sampling tube for mixed sample detection
This product is suitable for the preservation of strains.
To make contributions to the improvement of the health of the Chinese people! Founded in 2006, YOCON is a leading R&D service supplier of serum-free cell culture products and molecular diagnostic products in China, with 7 invention patents, 12 utility model patents, 1 registration certificate for Class II in vitro reagents, 24 filing certificates for Class I medical devices, and 5 software copyrights. It is qualified as a Zhongguancun high-tech enterprise and a national high-tech enterprise, having passed ISO9001 and ISO13485 certifications. The company is headquartered in Yongfeng Industrial Base, Haidian District, Beijing, with offices in Shanghai, Guangzhou, etc.
YOCON Biology was founded in 2006
12 utility model patents
R&D and production base covers area of 42,000 m2
Products are exported to over 40 countries
The company has the core technology by making continuous and independent innovation
The purpose of the production department is not to accept, manufacture or deliver nonconforming products
The company imposes strict control of the product quality by adhering to the policy of “fairness, scientificity, accuracy and rationality”
The 2023 International Bioprocessing Conference (BPI US) will be held from September 18th to 21st, 2023 at the Boston Convention and Exhibition Center in Massachusetts, USA.
New NK culture methods have emerged with a strong impact, assisting in the development of spot-type NK drugs
FaCHiP COVID-19 Antigen Test Kit (Colloidal Gold) newly developed by YOCON successfullyreceived the CE marking uniformly recognized by the EU authoritie
YOCON upcoming foam-free virus sampling tube can eliminate the foam. We have optimized the formulation of the reagent for inactivated virus to replace the substances that cause foaming, thus achieving the immediate elimination of foam throughout the proce
YOCON Biology (Beijing) Co., Ltd. has been successfully certified as a “National High-tech Enterprise” again by experts from the Ministry of Science and Technology, the Ministry of Finance and the State Administration of Taxation.
Lower requirements for initial blood samples; standard culture of different samples; stable achievement of more than 180-fold cell expansion with more than 70% positive rate; strong induction for special samples; breakthrough in NK cell apoptosis time ......
Cell Culture Media
Molecular Diagnostic